本文已被:浏览 998次 下载 280次 |
码上扫一扫! |
|
法尼酯X受体激动剂GW4064减轻小鼠脓毒症诱导的炎症反应和急性肾损伤 |
任婷1, 徐素娟1, 汪小燕1, 邹周平1, 丁小强1,2,3, 贾平1,2,3
|
1.复旦大学附属中山医院肾内科, 上海 200032;2.上海市肾病与透析研究所, 上海 200032;3.上海市肾脏疾病与血液净化重点实验室, 上海 200032
|
|
摘要: |
目的 利用小鼠脓毒症体内外模型,探讨法尼酯X受体(farnesoid X receptor,FXR)对脓毒症诱导的炎症反应和急性肾损伤的干预作用。方法 构建小鼠脓毒症模型,并随机分为4组:生理盐水(normal saline,NS)组、脂多糖(lipopolysaccharide,LPS)组、LPS+溶剂对照组(dimethyl sulfoxide,DMSO)和LPS+FXR激动剂(GW4064)组,每组5~8只。LPS组小鼠腹腔注射LPS(10 mg/kg),NS组小鼠腹腔注射等量生理盐水,后2组分别在LPS注射前5 d连续腹腔注射GW4064或DMSO。LPS注射后24 h留取血和肾脏标本,检测肾功能和炎症因子表达。在体外,利用LPS处理小鼠原代肾小管上皮细胞,分为4组:NS组、LPS组、LPS+溶剂对照组和LPS+GW4064组,RT-PCR测定上皮细胞促炎因子表达。结果 在小鼠脓毒症模型中,与NS对照组相比,LPS组小鼠肾脏促炎细胞因子白细胞介素6(interleukin 6,IL-6)、趋化因子配体2(C-C motif chemokine ligand 2,CCL2)表达显著上调(P<0.01),血肌酐明显升高(P<0.01);与LPS组和溶剂对照组小鼠相比,GW4064干预组血肌酐明显下降,肾脏病理损伤减轻,促炎细胞因子IL-6、CCL2表达下调。同时,LPS抑制肾脏FXR蛋白和FXR mRNA表达(P<0.05)。在小鼠体外实验中,LPS呈剂量依赖性抑制肾小管上皮细胞FXR表达(P<0.05);与LPS组和溶剂对照组相比,GW4064干预组可明显抑制肾小管上皮细胞促炎因子IL-6和CCL2表达(P<0.05)。结论 LPS可抑制肾脏FXR表达,FXR激活可减少LPS诱导的肾小管上皮细胞促炎因子生成,减轻肾脏炎症反应和急性肾损伤。 |
关键词: 法尼酯X受体 脂多糖 急性肾损伤 炎症反应 |
DOI:10.12025/j.issn.1008-6358.2022.20212744 |
分类号:R692 |
基金项目:国家自然科学基金(82170695),上海市科学技术委员会基金(14DZ2260200). |
|
FXR agonist GW4064 reduces sepsis-induced inflammation and acute kidney injury in mice |
REN Ting1, XU Su-juan1, WANG Xiao-yan1, ZOU Zhou-ping1, DING Xiao-qiang1,2,3, JIA Ping1,2,3
|
1.Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai 200032, China;2.Kidney and Dialysis Institute of Shanghai, Shanghai 200032, China;3.Kidney and Blood Purification Laboratory of Shanghai, Shanghai 200032, China
|
Abstract: |
Objective To explore the effect of farnesoid X receptor (FXR) on lipopolysaccharide (LPS)-induced inflammation and acute kidney injury (AKI) via sepsis model in vivo and in vitro. Methods Mouse sepsis model was established through LPS administration, and the experimental animals were randomly divided into four groups:normal saline (NS) group, LPS group, LPS+DMSO group, and LPS+GW4064 group. Each group contained 5-8 mice. Mice in LPS group were intraperitoneally injected with LPS at a dose of 10 mg/kg, and mice in NS group were injected with the equal volume of saline. The latter two groups were injected consecutively with GW4064 or vehicle for 5 days before LPS injection. Blood and kidney tissue were collected 24 hours after LPS injection to detect renal function and inflammatory factor expression. Primary tubular epithelial cells (PTECs) were isolated and treated with LPS in vitro and divided into four groups:NS group, LPS group, LPS+DMSO group, LPS+GW4064 group. The expression of proinflammatory factors was determined by RT-PCR. Results Compared with NS group, the expression of renal pro-inflammatory cytokines interleukin6(IL-6) and C-C motif chemokine ligand 2 (CCL2) in LPS group was significantly up-regulated (P<0.01), and the serum creatine level was increased (P<0.01). Compared with LPS group and vehicle group, serum creatine level in GW4064 intervention group was decreased (P<0.05), renal pathological injury was alleviated and the expression of inflammatory factors (IL-6 and CCL2)was down-regulated (P<0.05). At the same time, LPS inhibited FXR expression in protein and mRNA levels in kidney. Also LPS inhibited the expression of FXR in PTECs in vitro (P<0.05). Compared with LPS group and DMSO group, GW4064 intervention group significantly inhibited pro-inflammatory cytokines expression in PTECs (P<0.05). Conclusions LPS inhibits renal FXR expression. Activation of FXR reduces LPS-induced pro-inflammatory cytokines production in PTECs, and alleviates LPS-induce inflammation and AKI. |
Key words: farnesoid X receptor lipopolysaccharide acute kidney injury inflammation |